Endovascular Aneurysm Repair Devices Market Report 2026

Endovascular Aneurysm Repair Devices Market Overview

• Endovascular Aneurysm Repair Devices market size has reached to $2.62 billion in 2025 • Expected to grow to $3.78 billion in 2030 at a compound annual growth rate (CAGR) of 7.6% • Growth Driver: Impact Of Growing Demand For Minimally Invasive Surgical Treatments On The Market • Market Trend: Innovation In Abdominal Stent-Graft Systems Enhances EVAR Outcomes • North America was the largest region in 2025.

What Is Covered Under Endovascular Aneurysm Repair Devices Market?

Endovascular aneurysm repair (EVAR) devices are advanced medical tools designed for the minimally invasive treatment of aneurysms, particularly in the aorta. An aneurysm occurs when a section of a blood vessel wall weakens and bulges outward, posing a risk of rupture. EVAR devices aim to prevent rupture by reinforcing the blood vessel and redirecting blood flow away from the weakened area. The main aneurysm types in endovascular aneurysm repair devices are abdominal aortic aneurysms (AAA), thoracic aortic aneurysms (TAA), and peripheral aneurysms. An abdominal aortic aneurysm (AAA) is a condition where there is an abnormal bulge or dilation in the lower part of the aorta, the largest blood vessel in the body, which runs through the abdomen. It is applicable for endovascular grafts, stent-grafts, catheters, delivery systems, and imaging systems, and it caters to various end users, including hospitals, ambulatory surgical centers, and specialty clinics.

What Is The Endovascular Aneurysm Repair Devices Market Growth Forecast?

The endovascular aneurysm repair devices market size is expected to see strong growth in the next few years. It will grow to $3.78 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing adoption of next-generation stent-grafts, rising demand for personalized vascular implants, expansion of endovascular treatment capabilities, growing investments in hybrid operating rooms, increasing focus on long-term patient outcomes. Major trends in the forecast period include increasing adoption of minimally invasive aneurysm repair procedures, rising demand for advanced stent-graft technologies, growing use of image-guided endovascular systems, expansion of customized evar device designs, enhanced focus on procedure precision and safety.

Global Endovascular Aneurysm Repair Devices Market Segmentation

1) By Aneurysm Type: Abdominal Aortic Aneurysms (AAA), Thoracic Aortic Aneurysms (TAA), Peripheral Aneurysms 2) By Application: Endovascular Grafts, Stent-Grafts, Catheters, Delivery Systems, Imaging Systems 3) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics Subsegments: 1) By Abdominal Aortic Aneurysms (AAA): Infrarenal AAA, Juxtarenal AAA, Pararenal AAA 2) By Thoracic Aortic Aneurysms (TAA): Ascending Aortic Aneurysms, Aortic Arch Aneurysms, Descending Aortic Aneurysms 3) By Peripheral Aneurysms: Femoral Aneurysms, Popliteal Aneurysms, Iliac Aneurysms, Renal Aneurysms

What Is The Driver Of The Endovascular Aneurysm Repair Devices Market?

The growing demand for minimally invasive surgical treatments is expected to propel the growth of the endovascular aneurysm repair devices market going forward. Minimally invasive surgical treatments refer to medical procedures that are performed with minimal incisions or disruptions to the body, using specialized tools and techniques. The growing demand for minimally invasive surgical treatments is driven by factors such as reduced recovery time, lower risk of complications, smaller incisions leading to less pain, and improved precision and outcomes. Endovascular Aneurysm Repair (EVAR) devices enable minimally invasive surgeries by reinforcing blood vessel walls and redirecting blood flow, reducing the risk of aneurysm rupture. For instance, in January 2024, Intuitive Surgical Inc., a US-based manufacturer of robotic products, reported that they had placed 415 da Vinci surgical systems (robotic surgical systems that use a minimally invasive surgical approach) in the fourth quarter of 2023, representing a 12% increase compared to 2022. Therefore, the increase in the number of minimally invasive surgeries is driving the growth of the endovascular aneurysm repair devices industry.

Key Players In The Global Endovascular Aneurysm Repair Devices Market

Major companies operating in the endovascular aneurysm repair devices market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic Plc, Royal Philips, Boston Scientific, Terumo Corporation, Biotronik, L. Gore & Associates Inc., AorTech International, Teleflex Incorporated, Getinge AB, Cook Medical Group, Lombard Medical Technologies plc, Merit Medical Systems, Penumbra Inc., Volcano Corporation, Endologix Inc., Medico S.p.A, MicroPort Scientific Corporation

Global Endovascular Aneurysm Repair Devices Market Trends and Insights

Major companies operating in the endovascular aneurysm repair devices market are focusing on developing innovative solutions, such as abdominal stent-graft systems, to enhance patient outcomes by improving device durability, procedural success rates, and ease of deployment. An abdominal stent-graft system refers to a medical device used in endovascular aneurysm repair (EVAR) procedures to treat abdominal aortic aneurysms (AAA). For instance, in August 2024, Terumo India, an India-based medical technology company, launched the TREO Abdominal Stent-Graft System, a cutting-edge solution for treating abdominal aortic aneurysms (AAAs) in adults with suitable anatomies. This system features a unique three-piece design that includes both suprarenal and infrarenal active fixation capabilities, enhancing stability and effectiveness during endovascular aneurysm repair (EVAR). Key attributes include in situ limb adjustability for precise deployment, improved proximal sealing to prevent leaks, and superior lock stent technology to minimize migration risks.

What Are Latest Mergers And Acquisitions In The Endovascular Aneurysm Repair Devices Market?

In May 2023, Stryker Corporation, a US-based medical technology company, acquired Cerus Endovascular Ltd. for an undisclosed amount. With this acquisition, Stryker aims to enhance its portfolio of aneurysm treatment solutions by integrating innovative neurointerventional devices, thereby enabling physicians to treat a broader range of intracranial aneurysms more effectively. Cerus Endovascular Ltd is a US-based medical device company, specializing in neurovascular products, particularly for the treatment of intracranial aneurysms.

Regional Outlook

North America was the largest region in the endovascular aneurysm repair devices market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Endovascular Aneurysm Repair Devices Market?

The endovascular aneurysm repair devices market consists of sales of stent grafts, delivery systems, guidewires, anchoring devices, and endograft components. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.